Strategic Advisor

Helping healthcare and pharmaceutical leaders navigate complex systems and strategic decisions.

II work at the intersection of health markets, evidence, and strategy—supporting organizations in turning complexity into clear direction and long-term value.

View selected workGet in touch

Expertise & Domains

Core Competencies

A structured framework of expertise developed across 15+ years of strategic engagement with complex organizations. Each domain represents deep, applied knowledge in solving high-stakes challenges.

01

Health Market Strategy & Evidence

Translating epidemiology, clinical evidence, and real-world data into strategic positioning. Supporting pricing, access, portfolio prioritization, and long-term market strategy in complex regulatory environments.

Market Access Real-World Evidence Health Economics Portfolio Strategy
02

Strategic Use of Data

Using data not as an output, but as a decision instrument. Structuring information to clarify trade-offs, quantify uncertainty, and support defensible executive choices.

Decision Support Advanced Analytics Data-Driven Strategy Performance Intelligence
03

Health System Dynamics

Understanding how incentives, regulation, providers, payers, and industry interact within the broader health system. Identifying structural leverage points that influence adoption, reimbursement, and long-term value realization.

Health Policy Reimbursement Strategy Stakeholder Alignment System-Level Analysis
04

Executive Advisory & Positioning

Supporting senior leadership in navigating ambiguity. Integrating competitive intelligence, organizational capabilities, and market dynamics into coherent strategic direction.

Executive Counsel Strategic Positioning Competitive Landscape Long-Term Value Creation

Projects & Platforms

Selected Work

A curated selection of strategic initiatives developed across the healthcare and pharmaceutical ecosystem. These engagements address complex challenges - market access, evidence generation, health system dynamics, and strategic positioning - where rigorous analysis and clear judgment are required to guide high-stakes decisions.

Designing a methodological framework to transform public oncology data into structured evidence

Prisma Platform

Cliente: Novartis Public health data in Brazil holds immense potential for understanding how breast cancer care is delivered across the healthcare system. However, extracting meaningful insight from these datasets requires more than technical access - it demands a rigorous methodological approach capable of translating administrative data into reliable analytical evidence. Prisma Platform was developed to address this challenge.

Data Methodology Health Policy Health Strategy Oncology Public Policy

Transforming complex oncology data into accessible insight for patients, professionals, and policymakers

Atlas dos Centros de Cuidado do Câncer

Client: Oncoguia Understanding cancer care requires more than clinical knowledge. It requires visibility into how patients are diagnosed, treated, and supported across the healthcare system. The Atlas da Oncoguia was developed to make this reality more transparent.

Health Policy Health Systems Oncology Public Health Analytics

Revealing how oncology care actually happens inside the Brazilian health system

Radar do Câncer

Client: Oncoguia The Brazilian public health system produces an extraordinary volume of data. Yet much of it remains fragmented across multiple administrative databases, making it difficult to translate raw information into meaningful insights about how care is actually delivered. Radar do Câncer was created to address this gap.

Data Products Health Systems Healthcare Analytics Oncology Public Health Data

Thought Leadership

Publications & Speaking

A body of work focused on the intersection of healthcare systems, evidence, and strategic decision-making. Through publications, lectures, and executive discussions, these contributions explore how data, policy, and market dynamics shape access, innovation, and long-term value in healthcare.

Speaking2025

Real-World Evidence in Clinical Research: Concepts, Applications, and Strategic Impact

SBMF - Associação Brasileira de Medicina Farmacêutica - Evento "Dilemas da Pesquisa Clínica"

A talk on the role of real-world data and real-world evidence in expanding the understanding of treatment effectiveness and safety beyond controlled clinical trials. The presentation explored how RWD is reshaping clinical research and supporting better regulatory and healthcare decision-making.

Speaking2024

Data-Driven Decision-Making in Healthcare

IEEPO Roche

A presentation at Roche’s IEEPO (International Experience Exchange with Patient Organisations) on how data can strengthen healthcare decision-making. The talk explored how patient organizations and health leaders can leverage evidence and analytics to drive more informed and impactful decisions.

Speaking2023

Healthcare Financing: Cost or Investment?

10º Congresso Todos Juntos Contra o Câncer (TJCC)

A presentation at the Todos Juntos Contra o Câncer (TJCC) forum exploring the strategic perspective of healthcare financing in oncology. The talk examined whether health expenditures should be viewed as costs or as long-term investments in population health and system sustainability.

Poster2023

Patients’ epidemiology in stage III, unresectable non-small-cell lung carcinoma: A real-world analysis in Brazil.

Journal of Clinical Oncology - ASCO Annual Meeting

A real-world analysis of lung cancer treatment patterns in Brazil’s public health system, estimating the population of stage III unresectable NSCLC patients eligible for consolidation therapy after chemoradiation. The study provides strategic evidence to support planning, budget impact assessments, and policy decisions for the adoption of new oncology therapies in SUS.
Publication2023

Prevented cases of neural tube defects and cost savings after folic acid fortification of flour in Brazil

PLoS One

An economic analysis of neural tube defects in Brazil, evaluating the healthcare costs associated with these conditions and the impact of mandatory folic acid fortification. The study highlights how population-level prevention strategies can reduce disease burden and generate substantial savings for the health system.
Publication2022

Return to work after breast cancer: Disparities among patients treated in public and private hospitals in Brazil

San Antonio Breast Cancer Symposium

An analysis of return-to-work outcomes among Brazilian breast cancer survivors, examining how clinical, psychological, and workplace factors influence recovery and professional reintegration. The study highlights structural and organizational elements that shape patients’ ability to resume work after treatment.
Publication2022

Como uma ferramenta de prescrição eletrônica possibilita uma melhor qualidade na prescrição para os pacientes [PT-BR]

JBES - Jornal Brasileiro de Economia da Saúde

An analysis of medication errors and drug interactions based on electronic prescription data in Brazil. The study explores how digital prescribing systems can reduce preventable risks and improve medication safety in clinical practice.
Publication2021

Características demográficas e utilização de recursos por pacientes com dermatite atópica no Sistema Único de Saúde (SUS) [PT-BR]

JBES - Jornal Brasileiro de Economia da Saúde

A real-world analysis of atopic dermatitis in Brazil’s public health system, examining patient demographics and patterns of healthcare resource utilization. The study provides insights into the burden of the disease within SUS and its implications for clinical guidelines and treatment strategies.
Publication2019

How is advanced melanoma treated in the Public Health System in Brazil: a call for change.

Brasilian Journal of Oncology

A real-world analysis of advanced melanoma treatment in Brazil’s public health system, highlighting a significant gap between therapeutic innovation and the treatments patients actually receive.
Speaking2019

Big Data and Artificial Intelligence in Oncology: From Data to Predictive Decision-Making

VII International Lung Cancer Symposium

An opening keynote at the VII International Lung Cancer Symposium on the role of big data and artificial intelligence in healthcare. The talk explored how advanced analytics can improve interpretation, prediction, and decision-making in oncology.

Philosophy

On Approach & Mindset

Read Full Philosophy

I believe the most valuable work happens where rigorous evidence meets sound strategic judgment. Data can illuminate patterns and clarify trade-offs - but it is leadership and insight that ultimately determine direction.

In healthcare and the pharmaceutical industry, challenges rarely exist in isolation. Scientific evidence, regulatory environments, market access dynamics, and institutional incentives interact in ways that shape outcomes. My work focuses on helping leaders see these dynamics more clearly - so decisions are grounded not only in information, but in a coherent understanding of the system in which they operate.

Meaningful transformation requires more than technical capability. It requires the ability to translate complex realities into clear strategic choices, align stakeholders around a shared direction, and design solutions that create lasting value rather than temporary improvements.

Clarity Over Complexity

True understanding reveals what actually matters — and removes what does not.

Evidence Over Intuition

Strategy must be grounded in evidence, not intuition alone.

Impact Over Activity

The ultimate measure of strategic work is whether outcomes improve.

Insights

Recent Thinking

View All Insights

Contact

Strategic Conversations

For leaders and organizations seeking perspective on complex challenges within healthcare and the pharmaceutical ecosystem.

This channel is intended for substantive discussions on strategic direction, market dynamics, evidence generation, and high-impact decisions where independent advisory can provide clarity.

What to Expect

  • Response within 48-72 hours for qualified inquiries
  • Initial conversation to understand the context, decision environment, and strategic objectives.
  • Assessment of fit and, when appropriate, discussion of a potential advisory engagement.
Type of Inquiry